The key targets and signaling pathways of sulforaphane against colorectal cancer were analyzed based on network pharmacology
DOI:
https://doi.org/10.61173/j6x0nb03Keywords:
sulforaphane, colorectal cancer, network pharmacology, hub gene, protein-protein networkAbstract
Background: Sulforaphane is a dietary supplement molecule with a wide range of clinical applications, but its anti-colorectal cancer mechanism is not clearly understood. This paper was to systematically studied the molecular mechanism of sulforaphane against colorectal cancer by network pharmacology.Methods: The protein target was screened by SwissTargetPrediction, and the core target was analyzed by Cytoscape. Enrichment analysis and disease ontology analysis are then performed to generate a “gene-compound-disease” network to intuitively explore the underlying pharmacological mechanisms. Finally, the anti-colorectal cancer effect of sulforaphane was verified by CCK-8 in cell level.Results: Totally 43 targets were researched and the main anti-colorectal cancer mechanisms of sulforaphane were addressed. GAPDH, SRC, MAPK1, JAK2, GSK3B were identified as hub targets. The KEGG pathway mainly related to AGW-RAGE pathway and viral carcinogenesis.Conclusion: This study successfully identified the anti-colorectal cancer mechanism of sulforaphane (10 hub genes). In addition, sulforaphane can be further studied and developed as a lead compound. The findings here provide better guidance for follow-up experiments where we identify potentially active compounds for drug discovery or health promotion.References
Berry, M. D. (2004). Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders. J Psychiatry Neurosci, 29(5), 337-345. Biller, L. H., & Schrag, D. (2021). Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. Jama, 325(7), 669-685. doi:10.1001/jama.2021.0106 Butera, G., Mullappilly, N., Masetto, F., Palmieri, M., Scupoli, M. T., Pacchiana, R., & Donadelli, M. (2019). Regulation of Autophagy by Nuclear GAPDH and Its Aggregates in Cancer and Neurodegenerative Disorders. Int J Mol Sci, 20(9). doi:10.3390/ijms20092062 Hou, L., Li, G., Chen, Q., Zhao, J., Pan, J., Lin, R., . . . Wang, X. (2022). De novo full length transcriptome analysis and gene expression profiling to identify genes involved in phenylethanol glycosides biosynthesis in Cistanche tubulosa. BMC Genomics, 23(1), 698. doi:10.1186/ s12864-022-08921-x Hsu, W. C., Ramesh, S., Shibu, M. A., Chen, M. C., Wang, T. F., Day, C. H., . . . Huang, C. Y. (2021). Platycodin D reverses histone deacetylase inhibitor resistance in hepatocellular carcinoma cells by repressing ERK1/2-mediated cofilin-1 phosphorylation. Phytomedicine, 82, 153442. doi:10.1016/j.phymed.2020.153442 Iahtisham Ul, H., Khan, S., Awan, K. A., & Iqbal, M. J. (2022). Sulforaphane as a potential remedy against cancer: Comprehensive mechanistic review. J Food Biochem, 46(3), e13886. doi:10.1111/jfbc.13886 Liu, S., Li, Q., Li, G., Zhang, Q., Zhuo, L., Han, X., . . . Xie, T. (2020). The mechanism of m(6)A methyltransferase METTL3-mediated autophagy in reversing gefitinib resistance in NSCLC cells by β-elemene. Cell Death Dis, 11(11), 969. doi:10.1038/s41419-020-03148-8 Ma, G., Ren, Y., Wang, K., & He, J. (2011). SRC-3 has a role in cancer other than as a nuclear receptor coactivator. Int J Biol Sci, 7(5), 664-672. doi:10.7150/ijbs.7.664 Nogales, C., Mamdouh, Z. M., List, M., Kiel, C., Casas, A. I., & Schmidt, H. (2022). Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends Pharmacol Sci, 43(2), 136-150. doi:10.1016/ j.tips.2021.11.004 Qian, C. J., Yao, J., & Si, J. M. (2011). Nuclear JAK2: form and function in cancer. Anat Rec (Hoboken), 294(9), 1446-1459. doi:10.1002/ar.21443 Shang, L., Wang, Y., Li, J., Zhou, F., Xiao, K., Liu, Y., . . . Yang, S. (2023). Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharma-
Dean&Francis Zixin Zhou cology and experimental validation. J Ethnopharmacol, 302(Pt A), 115876. doi:10.1016/j.jep.2022.115876 Vanduchova, A., Anzenbacher, P., & Anzenbacherova, E. (2019). Isothiocyanate from Broccoli, Sulforaphane, and Its Properties. J Med Food, 22(2), 121-126. doi:10.1089/ jmf.2018.0024 Wang, Y., Guo, Z., Tian, Y., Cong, L., Zheng, Y., Wu, Z., . . . Song, Y. (2023). MAPK1 promotes the metastasis and invasion of gastric cancer as a bidirectional transcription factor. BMC Cancer, 23(1), 959. doi:10.1186/s12885-023- 11480-3 Zhang, J. Y., Zhang, F., Hong, C. Q., Giuliano, A. E., Cui, X. J., Zhou, G. J., . . . Cui, Y. K. (2015). Critical protein GAPDH and its regulatory mechanisms in cancer cells. Cancer Biol Med, 12(1), 10-22. doi:10.7497/ j.issn.2095-3941.2014.0019 Zheng, Y., Yang, Y., Zhu, W., Liu, R., Liu, A., Zhang, R., . . . Hu, Q. (2024). GSK3B inhibition reduced cervical cancer cell proliferation and migration by modulating the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition. Braz J Med Biol Res, 57, e13796. doi:10.1590/1414-431X2024e13796
Downloads
Published
Issue
Section
License
Copyright (c) 2024 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
